All Stories

  1. From genes to granulomas: the genetic blueprint of sarcoidosis

    Article • Current Opinion in Immunology, December 2025, Elsevier

    Natalia V Rivera

  2. Genetics in Sarcoidosis and Its Burden as a Multisystem Disease

    Article • Seminars in Respiratory and Critical Care Medicine, November 2025, Thieme Publishing Group

    Natalia V Rivera

  3. Sarcoidosis: A State-Of-The-Art Review

    Article • European Respiratory Journal, November 2025, European Respiratory Society (ERS)

    Francesco Bonella, Natalia V Rivera

  4. Sarcoidosis in the Genomic Era: From Genetic Drivers to Tailored Therapies

    Article • Current Allergy and Asthma Reports, September 2025, Springer Science + Business Media

    Natalia V Rivera

  5. Unraveling Genetics in Sarcoidosis: Next Steps

    Article • Archivos de Bronconeumología, September 2025, Elsevier

    Natalia V Rivera

  6. Clinical progression and genetic pathways in body-first and brain-first Parkinson’s disease

    Article • Molecular Neurodegeneration, June 2025, Springer Science + Business Media

    Natalia V Rivera

  7. Seasonal variation in Swedish sarcoidosis patients with severe hypercalcemia

    Article • Scientific Reports, February 2025, Springer Science + Business Media

    Natalia V Rivera

  8. Ethnicity-specific patterns of epigenetic age acceleration in rheumatoid arthritis

    Article • GeroScience, January 2025, Springer Science + Business Media

    Natalia V Rivera

  9. Unraveling genetic mysteries: phenotype-shaping profiles in chronic sarcoidosis

    Article • December 2024, Cold Spring Harbor Laboratory Press

    Natalia V Rivera

  10. Deciphering the genetic tapestry: Insights into sarcoidosis across diverse populations with the MESARGEN Consortium

    Article • September 2024, European Respiratory Society (ERS)

    Natalia V Rivera

  11. Sarcoidosis shares susceptibility loci with autoimmune disorders and cancers

    Article • September 2024, European Respiratory Society (ERS)

    Natalia V Rivera

  12. Big data in sarcoidosis

    Article • Current Opinion in Pulmonary Medicine, July 2024, Wolters Kluwer Health

    Natalia V Rivera

  13. Corrigendum: Sex differences in the genetics of sarcoidosis across European and African ancestry populations

    Article • Frontiers in Medicine, February 2024, Frontiers

    Natalia V Rivera

  14. Sex differences in the genetics of sarcoidosis across European and African ancestry populations

    Article • Frontiers in Medicine, May 2023, Frontiers

    Natalia V Rivera

  15. From Karl Wurm and Guy Scadding's staging to 18F-FDG PET/CT scan phenotyping and far beyond: perspective in the evading history of phenotyping in sarcoidosis

    Article • Frontiers in Medicine, May 2023, Frontiers

    Natalia V Rivera

  16. Peripheral blood lymphopenia in sarcoidosis associates with HLA-DRB1 alleles but not with lung immune cells and organ involvement

    Article • Clinical & Experimental Immunology, May 2023, Oxford University Press (OUP)

    Natalia V Rivera

  17. Maternal rheumatoid arthritis and risk of autism in the offspring

    Article • Psychological Medicine, April 2023, Cambridge University Press

    Natalia V Rivera

  18. Functional link between sarcoidosis-associated gene variants and quantitative levels of bronchoalveolar lavage fluid cell types

    Article • Frontiers in Medicine, February 2023, Frontiers

    Natalia V Rivera

  19. Genome-wide association analyses of physical activity and sedentary behavior provide insights into underlying mechanisms and roles in disease prevention

    Article • Nature Genetics, September 2022, Springer Science + Business Media

    Natalia V Rivera

  20. AB0091 INCREASED BIOLOGICAL AGE IN MALE PARTICIPANTS OF SWEDISH AND UK RHEUMATOID ARTHRITIS COHORTS IS NOT LINKED TO DISEASE

    Article • Annals of the Rheumatic Diseases, June 2022, Elsevier

    Natalia V Rivera

  21. AB0034 INVESTIGATING THE ROLE OF ACCELERATED IMMUNESENESCENCE IN THE PATHOGENESIS OF RHEUMATOID ARTHRITIS

    Article • Annals of the Rheumatic Diseases, June 2022, Elsevier

    Natalia V Rivera

  22. HLA-DRB1 alleles associate with hypercalcemia in sarcoidosis

    Article • Respiratory Medicine, October 2021, Elsevier

    Natalia V Rivera

  23. Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis

    Article • BMJ Open Respiratory Research, July 2021, BMJ

    Natalia V Rivera

  24. Recent advances in sarcoidosis genomics: epigenetics, gene expression, and gene by environment (G × E) interaction studies

    Article • Current Opinion in Pulmonary Medicine, July 2020, Wolters Kluwer Health

    Natalia V Rivera

  25. Changes in lung immune cells related to clinical outcome during treatment with infliximab for sarcoidosis

    Article • Clinical & Experimental Immunology, April 2020, Oxford University Press (OUP)

    Natalia V Rivera

  26. High-intensity resistance training in newly diagnosed sarcoidosis- an exploratory study of effects on lung function, muscle strength, fatigue, dyspnea, health-related quality of life and lung immune cells

    Article • European Clinical Respiratory Journal, January 2020, Taylor & Francis

    Natalia V Rivera

  27. A Gene–Environment Interaction Between Smoking and Gene polymorphisms Provides a High Risk of Two Subgroups of Sarcoidosis

    Article • Scientific Reports, December 2019, Springer Science + Business Media

    Natalia V Rivera

  28. Renal insufficiency following contrast media administration trial III: Urine flow rate‐guided versus left‐ventricular end‐diastolic pressure‐guided hydration in high‐risk patients for contrast‐induced acute kidney injury. Rationale and design

    Article • Catheterization and Cardiovascular Interventions, July 2019, Wiley

    Natalia V Rivera

  29. Genetic Architecture of Disease Chronicity in Sarcoidosis

    Article • May 2019, American Thoracic Society

    Natalia V Rivera

  30. A GWAS meta-analysis from 5 population-based cohorts implicates ion channel genes in the pathogenesis of irritable bowel syndrome

    Article • Neurogastroenterology & Motility, April 2018, Wiley

    Natalia V Rivera

  31. Correction: Genome-wide physical activity interactions in adiposity ― A meta-analysis of 200,452 adults

    Article • PLoS Genetics, August 2017, PLOS

    Natalia V Rivera

  32. Common variants of T-cells contribute differently to phenotypic variation in sarcoidosis

    Article • Scientific Reports, July 2017, Nature

    Natalia V Rivera

  33. Genome-wide physical activity interactions in adiposity ― A meta-analysis of 200,452 adults

    Article • PLoS Genetics, April 2017, PLOS

    Natalia V Rivera

  34. A meta-analysis of reflux genome-wide association studies in 6750 Northern Europeans from the general population

    Article • Neurogastroenterology & Motility, August 2016, Wiley

    Natalia V Rivera

  35. Approach for Identifying Human Leukocyte Antigen (HLA)-DR Bound Peptides from Scarce Clinical Samples

    Article • Molecular & Cellular Proteomics, July 2016, American Society for Biochemistry & Molecular Biology (ASBMB)

    Natalia V Rivera

  36. High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences

    Article • American Review of Respiratory Disease, May 2016, American Thoracic Society

    Natalia V Rivera

  37. The possible role of chromosome X variability in hypertensive familiarity

    Article • Journal of Human Hypertension, February 2016, Nature

    Natalia V Rivera, Gaetano Santulli

  38. T-cell receptor–HLA-DRB1 associations suggest specific antigens in pulmonary sarcoidosis

    Article • European Respiratory Journal, November 2015, European Respiratory Society (ERS)

    Natalia V Rivera

  39. TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives

    Article • Journal of Hypertension, June 2015, Wolters Kluwer Health

    Natalia V Rivera

  40. Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts

    Article • Gut, September 2014, BMJ

    Natalia V Rivera

  41. The Role of Adiposity in Cardiometabolic Traits: A Mendelian Randomization Analysis

    Article • PLoS Medicine, June 2013, PLOS

    Dr Massimo Mangino, Professor Dorret I Boomsma, Natalia V Rivera

  42. Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes

    Article • BMC Medical Genetics, January 2013, Springer Science + Business Media

    Natalia V Rivera

  43. Physical Activity Attenuates the Influence of FTO Variants on Obesity Risk: A Meta-Analysis of 218,166 Adults and 19,268 Children

    Article • PLoS Medicine, November 2011, PLOS

    Dr Massimo Mangino, Natalia V Rivera, Dr Simin Liu, Dr Ulla Sovio

  44. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design

    Article • EuroIntervention, April 2011, Europa Digital & Publishing

    Natalia V Rivera

  45. Reply to Letter Regarding Article, "Cystatin C and Contrast-Induced Acute Kidney Injury"

    Article • Circulation, February 2011, Wolters Kluwer Health

    Natalia V Rivera

  46. Cystatin C and Contrast-Induced Acute Kidney Injury

    Article • Circulation, May 2010, Wolters Kluwer Health

    Natalia V Rivera

  47. Correlations between progression of coronary artery disease and circulating endothelial progenitor cells

    Article • The FASEB Journal, January 2010, Federation of American Societies For Experimental Biology (FASEB)

    Natalia V Rivera

  48. Contrast agents and renal cell apoptosis

    Article • European Heart Journal, May 2008, European Society of Cardiology

    Natalia V Rivera